Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction
Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a...
Gespeichert in:
| Veröffentlicht in: | Headache 2006-02, Vol.46 (2), p.332-335 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 335 |
|---|---|
| container_issue | 2 |
| container_start_page | 332 |
| container_title | Headache |
| container_volume | 46 |
| creator | Wheeler, Steve D |
| description | Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a cholinesterase inhibitor. Although, the mechanism responsible for this effect is uncertain, cholinesterase inhibition resulting in cholinergic augmentation and enhanced cognition probably account for some if not most of the improvement. |
| doi_str_mv | 10.1111/j.1526-4610.2006.00348_1.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_20076276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20076276</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_200762763</originalsourceid><addsrcrecordid>eNqNjj0PgjAURRujifjxHxoHN_AVsaArapw0MeykwYepKS3SYtRfL4Nx9i4nuecOl5AZg4B1WdwCtgq5H_GuCAF4ALCMkpwFzx7xfqpPPAAW-0kcJUMysvYGABFfc4-cUiW1LISiR-PQbujWaKzxLRXNGhSuQu2oKWlmatmISjj0z6g6XGhqrlo6-UC6fdmy1YWTRk_IoBTK4vTLMZnvd1l68OvG3Fu0Lq-kLVApodG0Nu9OxzyM-fLv4QeoBEq5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20076276</pqid></control><display><type>article</type><title>Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction</title><source>Wiley Online Library All Journals</source><creator>Wheeler, Steve D</creator><creatorcontrib>Wheeler, Steve D</creatorcontrib><description>Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a cholinesterase inhibitor. Although, the mechanism responsible for this effect is uncertain, cholinesterase inhibition resulting in cholinergic augmentation and enhanced cognition probably account for some if not most of the improvement.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/j.1526-4610.2006.00348_1.x</identifier><language>eng</language><ispartof>Headache, 2006-02, Vol.46 (2), p.332-335</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Wheeler, Steve D</creatorcontrib><title>Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction</title><title>Headache</title><description>Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a cholinesterase inhibitor. Although, the mechanism responsible for this effect is uncertain, cholinesterase inhibition resulting in cholinergic augmentation and enhanced cognition probably account for some if not most of the improvement.</description><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjj0PgjAURRujifjxHxoHN_AVsaArapw0MeykwYepKS3SYtRfL4Nx9i4nuecOl5AZg4B1WdwCtgq5H_GuCAF4ALCMkpwFzx7xfqpPPAAW-0kcJUMysvYGABFfc4-cUiW1LISiR-PQbujWaKzxLRXNGhSuQu2oKWlmatmISjj0z6g6XGhqrlo6-UC6fdmy1YWTRk_IoBTK4vTLMZnvd1l68OvG3Fu0Lq-kLVApodG0Nu9OxzyM-fLv4QeoBEq5</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Wheeler, Steve D</creator><scope>7TK</scope></search><sort><creationdate>20060201</creationdate><title>Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction</title><author>Wheeler, Steve D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_200762763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wheeler, Steve D</creatorcontrib><collection>Neurosciences Abstracts</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wheeler, Steve D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction</atitle><jtitle>Headache</jtitle><date>2006-02-01</date><risdate>2006</risdate><volume>46</volume><issue>2</issue><spage>332</spage><epage>335</epage><pages>332-335</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><abstract>Six migraine patients experienced significant topiramate-related cognitive and language dysfunction that improved with donepezil treatment and allowed uninterrupted topiramate use. These patients represent the first report of topiramate-related cognitive and language dysfunction that improved with a cholinesterase inhibitor. Although, the mechanism responsible for this effect is uncertain, cholinesterase inhibition resulting in cholinergic augmentation and enhanced cognition probably account for some if not most of the improvement.</abstract><doi>10.1111/j.1526-4610.2006.00348_1.x</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0017-8748 |
| ispartof | Headache, 2006-02, Vol.46 (2), p.332-335 |
| issn | 0017-8748 1526-4610 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_20076276 |
| source | Wiley Online Library All Journals |
| title | Clinical Notes: Donepezil Treatment of Topiramate-Related Cognitive Dysfunction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A04%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Notes:%20Donepezil%20Treatment%20of%20Topiramate-Related%20Cognitive%20Dysfunction&rft.jtitle=Headache&rft.au=Wheeler,%20Steve%20D&rft.date=2006-02-01&rft.volume=46&rft.issue=2&rft.spage=332&rft.epage=335&rft.pages=332-335&rft.issn=0017-8748&rft.eissn=1526-4610&rft_id=info:doi/10.1111/j.1526-4610.2006.00348_1.x&rft_dat=%3Cproquest%3E20076276%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20076276&rft_id=info:pmid/&rfr_iscdi=true |